市場調査レポート

商品コード

内皮機能障害の2028年までの市場予測-原因、検査タイプ、エンドユーザー別の世界分析

Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause, Test Type, and End User

出版日: 2023年08月09日 | 発行: The Insight Partners

| ページ情報: 英文 198 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 712,757円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,026,057円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,339,357円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.65円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の内皮機能障害市場規模は2022年に19億9,517万米ドルと評価され、2028年には25億8,484万米ドルに達すると予測され、市場は2022年から2028年にかけて4.4%のCAGRを記録すると推定されます。市場の成長は、心血管疾患の罹患率の増加、高コレステロール、糖尿病、肥満の罹患率の上昇に起因しています。

世界保健機関（WHO）によると、心血管疾患（CVD）は世界の主要な死因のひとつであり、毎年3,000万人が脳卒中を経験しています。CVDには、脳血管疾患、冠動脈疾患、リウマチ性心疾患、冠動脈疾患（CAD）などが含まれます。CADはすべての心血管系疾患の中で最も一般的な疾患であり、冠動脈の内皮下腔における脂質と免疫細胞の蓄積、すなわちアテローム性動脈硬化を特徴とします。血管内皮の炎症反応が関与しています。CADはアテローム性動脈硬化による冠動脈内腔の狭窄、攣縮、閉塞に起因する心筋の虚血、低酸素、壊死を特徴とします。世界的に死因の第1位となっています。米国疾病予防管理センター（CDC）によると、米国では6,000万人以上の女性（44％）が何らかの心臓病を患っています。心臓病は米国の女性の死因の第1位であり、年齢に関係なく罹患する可能性があります。2021年には、女性の死因のほぼ5人に1人にあたる310,661人が心臓病で亡くなっています。ニューデリーにある国立心臓研究所のC.E.O.兼主任心臓外科医であるO.ヤダヴァ博士による「若いインド人は冠動脈疾患のリスクが高い」と題された論文によると、現在の科学的証拠は驚くべき結果を示しています。欧米におけるCADの有病率は、過去30年間で半減しました。しかし、インドでは倍増しており、減少の兆しはないです。

米国心臓協会によると、米国では成人のほぼ半数が何らかのCVDに罹患しています。2035年までに1億3,000万人以上、すなわち米国人口の45.1％が何らかのCVDに罹患すると予測されています。欧州心臓病学会の報告によると、CVDは欧州で390万人、欧州連合（EU）で180万人以上の死亡原因となっています。つまり、欧州における全死亡の45％を占めています。過去25年間、欧州ではCVD症例の絶対数と新規CVD症例数が増加しています。中欧および西欧では、男性の喫煙習慣や多量の飲酒により、心血管危険因子の有病率が高いです。年間400万人以上の欧州人が、主に冠動脈疾患（CHD）と脳卒中による心血管疾患で死亡しています。報告書"Beyond the Burden：2019年に出版されたバイオセンス・ウェブスター社の報告書"アジア太平洋における心房細動の影響"によると、アジア太平洋では1,600万人以上が心房細動に苦しんでおり、2050年には7,200万人に達すると予想されています。この報告書はまた、中高年層がこの症状を発症しやすいことを示唆しています。

世界心臓連盟によると、中東・北アフリカでは心血管系疾患が主な死因であり、全死亡の3分の1以上、年間140万人を占めています。さらに、CVDによる死亡は過去30年間で48％増加しており、オマーンとソマリアではそれぞれ死亡の40％と10％を占めています。2021年の中東・北アフリカにおける年齢標準化CVD死亡率は、人口10万人当たり134.2～600.2人でした。

したがって、心血管疾患の有病率の高さが内皮機能障害市場の成長を促進すると考えられます。

製品ベースの洞察

内皮機能障害市場は、原因別に高血圧、糖尿病、高コレステロール血症、ベーチェット病、肥満、その他に区分されます。2022年の市場では、高血圧セグメントが最大のシェアを占めています。しかし、糖尿病セグメントは2022～2028年の間に市場で最も高いCAGR 4.6%を記録すると予測されています。心血管合併症は、糖尿病による慢性血管合併症の結果です。多くの調査論文で、インスリン抵抗性と内皮機能障害の関連性が示されています。しかし、糖尿病が内皮にどのような影響を及ぼすかはまだ解明されていないです。糖尿病は動脈硬化性疾患、網膜症、腎症、神経障害などの微小血管病変のリスクに直接関係しています。したがって、糖尿病患者では心血管疾患のリスクが指数関数的に増加します。2020年5月にMDPIジャーナルから発表された研究論文「糖尿病における内皮機能障害」によると、空腹時血糖障害（IFG）や耐糖能障害（IGT）などの糖尿病前症の患者にも、内皮機能障害をイベントとして示唆するエビデンスが蓄積しています。上記の要因を考慮すると、内皮機能障害治療の需要は指数関数的に増加すると推定されます。

原因に基づく洞察

原因に基づき、内皮機能障害市場は高血圧、糖尿病、高コレステロール血症、ベーチェット病、肥満、その他に区分されます。2022年の内皮機能障害市場シェアは高血圧が最大でした。糖尿病セグメントは2022年から2028年にかけて最も高いCAGRを記録すると予測されています。

エンドユーザーに基づく洞察

エンドユーザーに基づき、内皮機能障害市場は病院、診断センター、診療所、その他に分類されます。病院は2022年に最大の市場シェアホルダーであり、2022年から2028年にかけて最も高いCAGRを記録すると予測されています。

さらに、糖尿病患者数は世界中で広く増加しています。国際糖尿病連合（IDF）によると、2045年までに糖尿病患者数は2020年の4億2,500万人から6億人に増加します。したがって、糖尿病患者の増加は、糖尿病セグメントの内皮機能障害市場の成長を促進します。

市場促進要因
- 心血管疾患の増加
- 高コレステロール、糖尿病、肥満の増加
市場抑制要因
- 内皮機能障害のスクリーニング技術に伴う欠点
市場機会
- 新規バイオマーカーと治療戦略の利用増加
今後の動向
- 内皮機能障害を評価するための非侵襲的方法の使用
影響分析

第6章内皮機能障害市場-世界分析

内皮機能障害の世界市場収益と予測分析
内皮機能障害の世界市場：地域別予測・分析
主要参入企業の市場ポジショニング

第7章内皮機能障害市場の分析-原因別

概要
内皮機能障害市場：原因別、2022年・2028年（%）
高血圧
糖尿病
高コレステロール血症
ベーチェット病
肥満症
その他

第8章内皮機能障害市場の分析-検査タイプ別

概要
内皮機能障害市場：検査タイプ別、2022年・2028年（%）
侵襲的検査
非侵襲的検査

第9章内皮機能障害市場の分析-エンドユーザー別

概要
内皮機能障害市場：エンドユーザー別、2022年・2028年（%）
病院
診断センター
診療所
その他

第10章内皮機能障害市場：2028年までの収益と予測：地域分析

北米
欧州
アジア太平洋
中東&アフリカ
中南米

第11章内皮機能障害市場へのCOVID-19パンデミックの影響

北米
欧州
アジア太平洋
中南米
中東・アフリカ

第12章内皮機能障害市場-業界情勢

内皮機能障害市場における成長戦略
無機的成長戦略
有機的成長戦略

第13章企業プロファイル

ZOLL Medical Corp
Sphingo Tec GmbH
Lawrence Berkeley National Laboratory
The Polymath Co
Endothelix Inc
Perimed AB
SMART Medical Ltd
Everist Health Inc
Alam Medical SaRl
Medizinische Messtechnik GmbH

第14章付録

図表

List Of Tables

Table 1. Techniques Used in to Assess Endothelial Function
Table 2. Novel Soluble and Cell Component Biomarkers of Endothelia Dysfunction in Cardiovascular Diseases
Table 3. North America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 8. US Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 10. US Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. UK Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 28. UK Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 29. UK Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 30. UK Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. France Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 32. France Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 33. France Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 34. France Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 38. Italy Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 42. Spain Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Europe Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 50. Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. China Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 52. China Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 53. China Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 54. China Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 57. Japan Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 58. Japan Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 59. India Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 60. India Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 61. India Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 62. India Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 66. Australia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 67. South Korea Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 68. South Korea Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 69. South Korea Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 70. South Korea Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Asia Pacific Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of Asia Pacific Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East & Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 77. Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
Table 78. Middle East & Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 81. Saudi Arabia Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 82. Saudi Arabia Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 83. UAE Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 84. UAE Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 85. UAE Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 86. UAE Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 89. South Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 90. South Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East & Africa Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 93. Rest of Middle East & Africa Endothelial Dysfunction Market, by Non-Invasive Tests- Revenue and Forecast to 2028 (US$ Million)
Table 94. Rest of Middle East & Africa Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 95. South & Central America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 96. South & Central America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 97. South & Central America Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 98. South & Central America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 101. Brazil Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 102. Brazil Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 105. Argentina Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 106. Argentina Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South & Central America Endothelial Dysfunction Market, by Cause - Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South & Central America Endothelial Dysfunction Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 109. Rest of South & Central America Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
Table 110. Rest of South & Central America Endothelial Dysfunction Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 111. Recent Inorganic Growth Strategies in the Endothelial Dysfunction Market
Table 112. Recent Organic Growth Strategies in the Endothelial Dysfunction Market
Table 113. Glossary of Terms, Endothelial dysfunction market

List Of Figures

Figure 1. Endothelial Dysfunction Market Segmentation
Figure 2. Endothelial Dysfunction Market by Region
Figure 3. Global Endothelial Dysfunction Market Overview
Figure 4. Hypertension Account for Largest Share of Cause Segment in Endothelial Dysfunction Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Endothelial Dysfunction Market, by Geography (US$ Million)
Figure 7. Global Endothelial Dysfunction Market - Leading Country Markets (US$ Million)
Figure 8. Global Endothelial Dysfunction Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Endothelial Dysfunction Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Endothelial Dysfunction Market - Revenue Forecast and Analysis - 2020-2028
Figure 16. Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Endothelial Dysfunction Market
Figure 18. Endothelial Dysfunction Market, by Cause, 2022 & 2028 (%)
Figure 19. Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Behcet's disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Endothelial Dysfunction Market, by Test Type, 2022 & 2028 (%)
Figure 26. Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 29. Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Endothelial Dysfunction Market, by End User, 2022 & 2028 (%)
Figure 34. Hospitals and Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 39. North America Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 41. US: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 45. Europe Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 47. Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. UK: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. France: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 54. Asia Pacific Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Asia Pacific: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 56. China: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 58. India: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East & Africa: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 63. Middle East & Africa Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East & Africa: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 65. Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 67. South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. South & Central America: Endothelial Dysfunction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 70. South & Central America Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. South & Central America: Endothelial Dysfunction Market, by Country, 2022 & 2028 (%)
Figure 72. Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 74. Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2028 (US$ Million)
Figure 75. Impact of COVID-19 Pandemic on North American Countries Markets
Figure 76. Impact of COVID-19 Pandemic on European Countries Markets
Figure 77. Impact of COVID-19 Pandemic on Asia Pacific Countries Markets
Figure 78. Impact of COVID-19 Pandemic on South & Central American Countries Markets
Figure 79. Impact of COVID-19 Pandemic on Middle East & African Countries Markets
Figure 80. Growth Strategies in the Endothelial Dysfunction Market

Product Code: TIPRE00011290

The global endothelial dysfunction market size was valued at US$ 1,995.17 million in 2022 and is expected to reach a value of US$ 2,584.84 million by 2028; the market is estimated to record a CAGR of 4.4% from 2022 to 2028. The market growth is attributed to increasing incidence of cardiovascular diseases and rising incidence of high cholesterol, diabetes, and obesity.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are among the leading causes of death worldwide, and ~30 million people experience a stroke each year. CVDs include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and coronary artery disease (CAD). CAD is the most common disease among all cardiovascular diseases, and it is characterized by the accumulation of lipids and immune cells in the subendothelial space of the coronary arteries or atherosclerosis. It involves the inflammatory response of the vascular endothelium. CAD is characterized by ischemia, hypoxia, or necrosis of the myocardium resulting from narrowing, spasm, or obstruction of the coronary artery lumen by atherosclerosis. It has become the leading cause of death worldwide. According to the Centers for Disease Control and Prevention (CDC), over 60 million women (44%) in the US suffer from some form of heart disease. Heart disease is the leading cause of death among women in the US and can affect women of any age. In 2021, it caused 310,661 deaths among women, i.e., nearly one in five female deaths. According to an article entitled "Young Indians Are at Higher Risk of Coronary Artery Disease," by Dr. O. Yadava, C.E.O. & Chief Cardiac Surgeon, National Heart Institute, New Delhi, current scientific evidence shows alarming results; CAD rates among Indians are staggering 50-400% higher than any other ethnic group. The prevalence of CAD in the West has fallen by half over the past three decades. However, the rates in India have doubled, and there is no sign of a decline.

According to the American Heart Association, almost half of all adults in the US suffer from a type of CVD. Over 130 million people, i.e., 45.1% of the US population, are projected to suffer from a type of CVD by 2035. According to reports by the European Society of Cardiology, CVDs cause 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). In short, they account for 45% of all deaths in Europe. Over the past 25 years, the absolute number of CVD cases and new CVD cases have increased in Europe. There is a high prevalence of cardiovascular risk factors in Central and Western Europe owing to smoking habits and heavy drinking rates among men. More than 4 million Europeans die yearly from cardiovascular diseases mainly due to coronary artery disease (CHD) and stroke. As per the report "Beyond the Burden: The Impact of Atrial Fibrillation in Asia Pacific," by Biosense Webster, published in 2019, more than 16 million people in Asia Pacific suffer from atrial fibrillation, which is expected to reach ~72 million by 2050. The report also suggests that the middle-aged and elderly population is more prone to develop this condition.

According to the World Heart Federation, cardiovascular disease is the primary cause of death in the Middle East & North Africa, accounting for more than a third of all deaths or 1.4 million people annually. Further, CVD deaths have increased by 48% over the past 30 years, which accounted for 40% and 10% of deaths in Oman and Somalia, respectively. In 2021, age-standardized CVD mortality rates in the Middle East & North Africa ranged from 134.2 to 600.2 per 100,000 people.

Therefore, the high prevalence of cardiovascular diseases is likely to drive the endothelial dysfunction market growth.

Product-Based Insights

The endothelial dysfunction market, based on cause, is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. The hypertension segment held the largest share of the market in 2022. However, diabetes segment is anticipated to register the highest CAGR of 4.6% in the market during 2022-2028. Cardiovascular complications are the results of chronic vascular complications caused by diabetes. Many research articles have shown links between insulin resistance and endothelial dysfunction. However, it is still not understood how diabetes affects endothelium. Diabetes is directly related to risks of microvascular pathologies, such as atherosclerotic diseases, retinopathy, nephropathy, and neuropathy. Thus, the risk of cardiovascular disease increases exponentially in patients suffering from diabetes. According to the research article 'Endothelial Dysfunction in Diabetes,' published in May 2020 by MDPI journals, patients with prediabetic conditions, such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), also show accumulating evidence that implicates endothelial dysfunction as an event. Considering the above-listed factors, the demand for endothelial dysfunction treatment is estimated to increase exponentially.

Cause-Based Insights

Based on cause, the endothelial dysfunction market is segmented into hypertension, diabetes, hypercholestrolaemia, Bechet's disease, obesity, and others. Hypertension was the largest endothelial dysfunction market share holder in 2022. The diabetes segment is anticipated to register the highest CAGR from 2022 to 2028.

End User-Based Insights

Based on end user, the endothelial dysfunction market is categorized into hospitals, diagnostic centers, clinics, and others. Hospitals was the largest market share holder in 2022 and is anticipated to register the highest CAGR from 2022 to 2028.

Further, the number of people with diabetes is growing widely worldwide. According to the International Diabetes Federation (IDF), by 2045, the number of people with diabetes will rise to 600 million from 425 million in 2020. Thus, the growing number of diabetic people drives the endothelial dysfunction market growth for the diabetes segment.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the endothelial dysfunction market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Endothelial Dysfunction Market - by Cause
- 1.3.2 Global Endothelial Dysfunction Market - by Test Type
- 1.3.3 Global Endothelial Dysfunction Market - by End User
- 1.3.4 Global Endothelial Dysfunction Market - by Geography

2. Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Endothelial Dysfunction Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion

5. Endothelial Dysfunction Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidences of Cardiovascular Diseases
- 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
- 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
- 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
- 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis

6. Endothelial Dysfunction Market - Global Analysis

6.1 Global Endothelial Dysfunction Market Revenue Forecast and Analysis
6.2 Global Endothelial Dysfunction Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Endothelial Dysfunction Market Analysis - by Cause

7.1 Overview
7.2 Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
- 7.3.1 Overview
- 7.3.2 Hypertension: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
- 7.4.1 Overview
- 7.4.2 Diabetes: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
- 7.5.1 Overview
- 7.5.2 Hypercholestrolaemia: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet's Disease
- 7.6.1 Overview
- 7.6.2 Behcet's Disease: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
- 7.7.1 Overview
- 7.7.2 Obesity: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Endothelial Dysfunction Market Analysis - by Test Type

8.1 Overview
8.2 Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
- 8.3.1 Overview
- 8.3.2 Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
- 8.4.1 Overview
- 8.4.2 Non-Invasive Tests: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Flow Mediated Dilatory
  - 8.4.3.1 Overview
  - 8.4.3.2 Flow Mediated Dilatory: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.4 Venous Occlusion Plethysmography
  - 8.4.4.1 Overview
  - 8.4.4.2 Venous Occlusion Plethysmography: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.5 Peripheral Arterial Tonometry (PAT)
  - 8.4.5.1 Overview
  - 8.4.5.2 Peripheral Arterial Tonometry (PAT): Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Circulating Markers
  - 8.4.6.1 Overview
  - 8.4.6.2 Circulating Markers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.7 Others
  - 8.4.7.1 Overview
  - 8.4.7.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Endothelial Dysfunction Market Analysis - by End User

9.1 Overview
9.2 Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
- 9.4.1 Overview
- 9.4.2 Diagnostics Centers: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
- 9.5.1 Overview
- 9.5.2 Clinics: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Geographic Analysis

10.1 North America: Endothelial Dysfunction Market
- 10.1.1 Overview
- 10.1.2 North America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.1.3 North America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.1.4 North America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
  - 10.1.4.1 North America: Endothelial Dysfunction Market, by Non-Invasive Tests- 2020-2028 (US$ Million)
- 10.1.5 North America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.5.1 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.1.1 Overview
    - 10.1.5.1.2 US: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.1.3 US: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.5.1.4 US: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.1.5.1.4.1 US: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.1.5 US: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.5.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.2.1 Overview
    - 10.1.5.2.2 Canada: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.2.3 Canada: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.5.2.4 Canada: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.1.5.2.4.1 Canada: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.2.5 Canada: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.5.3 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.3.1 Overview
    - 10.1.5.3.2 Mexico: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.5.3.3 Mexico: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.5.3.4 Mexico: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.1.5.3.4.1 Mexico: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.5.3.5 Mexico: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.2 Europe: Endothelial Dysfunction Market
- 10.2.1 Overview
- 10.2.2 Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.2.3 Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.2.4 Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
  - 10.2.4.1 Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
- 10.2.5 Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.1 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.1.1 Overview
    - 10.2.5.1.2 Germany: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.1.3 Germany: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.1.4 Germany: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.1.4.1 Germany: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.1.5 Germany: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.2.1 Overview
    - 10.2.5.2.2 UK: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.2.3 UK: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.2.4 UK: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.2.4.1 UK: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.2.5 UK: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.3 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.3.1 Overview
    - 10.2.5.3.2 France: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.3.3 France: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.3.4 France: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.3.4.1 France: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.3.5 France: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.4 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.4.1 Overview
    - 10.2.5.4.2 Italy: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.4.3 Italy: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.4.4 Italy: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.4.4.1 Italy: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.4.5 Italy: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.5 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.5.1 Overview
    - 10.2.5.5.2 Spain: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.5.3 Spain: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.5.4 Spain: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.5.4.1 Spain: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.5.5 Spain: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.2.5.6 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.6.1 Overview
    - 10.2.5.6.2 Rest of Europe: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.2.5.6.3 Rest of Europe: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.2.5.6.4 Rest of Europe: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.2.5.6.4.1 Rest of Europe: Endothelial Dysfunction Market, by Non-Invasive Tests - Revenue and Forecast to 2028 (US$ Million)
    - 10.2.5.6.5 Rest of Europe: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.3 Asia Pacific: Endothelial Dysfunction Market
- 10.3.1 Overview
- 10.3.2 Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3.3 Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.3.4 Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
  - 10.3.4.1 Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.3.5 Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.1 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.1.1 Overview
    - 10.3.5.1.2 China: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.1.3 China: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.1.4 China: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.1.4.1 China: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.1.5 China: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.2.1 Overview
    - 10.3.5.2.2 Japan: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.2.3 Japan: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.2.4 Japan: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.2.4.1 Japan: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.2.5 Japan: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.3 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.3.1 Overview
    - 10.3.5.3.2 India: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.3.3 India: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.3.4 India: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.3.4.1 India: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.3.5 India: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.4 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.4.1 Overview
    - 10.3.5.4.2 Australia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.4.3 Australia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.4.4 Australia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.4.4.1 Australia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.4.5 Australia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.5 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.5.1 Overview
    - 10.3.5.5.2 South Korea: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.5.3 South Korea: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.5.4 South Korea: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.5.4.1 South Korea: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.5.5 South Korea: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.3.5.6 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.6.1 Overview
    - 10.3.5.6.2 Rest of Asia Pacific: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.3.5.6.3 Rest of Asia Pacific: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.3.5.6.4 Rest of Asia Pacific: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.3.5.6.4.1 Rest of Asia Pacific: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.3.5.6.5 Rest of Asia Pacific: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.4 Middle East & Africa: Endothelial Dysfunction Market
- 10.4.1 Overview
- 10.4.2 Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4.3 Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.4.4 Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
  - 10.4.4.1 Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
- 10.4.5 Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.1 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.1.1 Overview
    - 10.4.5.1.2 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.1.3 Saudi Arabia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.1.4 Saudi Arabia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.1.4.1 Saudi Arabia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.1.5 Saudi Arabia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.2.1 Overview
    - 10.4.5.2.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.2.3 UAE: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.2.4 UAE: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.2.4.1 UAE: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.2.5 UAE: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.3 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.3.1 Overview
    - 10.4.5.3.2 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.3.3 South Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.3.4 South Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.3.4.1 South Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.3.5 South Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.4.5.4 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.4.1 Overview
    - 10.4.5.4.2 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.4.5.4.3 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.4.5.4.4 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.4.5.4.4.1 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.4.5.4.5 Rest of Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
10.5 South & Central America: Endothelial Dysfunction Market
- 10.5.1 Overview
- 10.5.2 South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5.3 South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
- 10.5.4 South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
  - 10.5.4.1 South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
- 10.5.5 South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.5.5.1 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.1.1 Overview
    - 10.5.5.1.2 Brazil: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.1.3 Brazil: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.5.5.1.4 Brazil: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.5.5.1.4.1 Brazil: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.1.5 Brazil: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.5.5.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.2.1 Overview
    - 10.5.5.2.2 Argentina: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.2.3 Argentina: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.5.5.2.4 Argentina: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.5.5.2.4.1 Argentina: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.2.5 Argentina: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.5.5.3 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.3.1 Overview
    - 10.5.5.3.2 Rest of South & Central America: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.5.5.3.3 Rest of South & Central America: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.5.5.3.4 Rest of South & Central America: Endothelial Dysfunction Market, by Test Type - 2020-2028 (US$ Million)
    - 10.5.5.3.4.1 Rest of South & Central America: Endothelial Dysfunction Market, by Non-Invasive Test - Revenue and Forecast to 2028 (US$ Million)
    - 10.5.5.3.5 Rest of South & Central America: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Endothelial Dysfunction Market

11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Endothelial Dysfunction Market-Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Endothelial Dysfunction Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 ZOLL Medical Corp
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Sphingo Tec GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Lawrence Berkeley National Laboratory
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 The Polymath Co
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Endothelix Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Perimed AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 SMART Medical Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Everist Health Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Alam Medical SaRl
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Medizinische Messtechnik GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms

内皮機能障害の2028年までの市場予測-原因、検査タイプ、エンドユーザー別の世界分析

Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause, Test Type, and End User

目次

第1章イントロダクション

第2章内皮機能障害市場-主要な要点

第3章調査手法

第4章内皮機能障害市場- 市場情勢

第5章内皮機能障害市場：主要市場力学

第6章内皮機能障害市場-世界分析

第7章内皮機能障害市場の分析-原因別

第8章内皮機能障害市場の分析-検査タイプ別

第9章内皮機能障害市場の分析-エンドユーザー別

第10章内皮機能障害市場：2028年までの収益と予測：地域分析

第11章内皮機能障害市場へのCOVID-19パンデミックの影響

第12章内皮機能障害市場-業界情勢

第13章企業プロファイル

第14章付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

4. Endothelial Dysfunction Market - Market Landscape

5. Endothelial Dysfunction Market - Key Market Dynamics

6. Endothelial Dysfunction Market - Global Analysis

7. Endothelial Dysfunction Market Analysis - by Cause

8. Endothelial Dysfunction Market Analysis - by Test Type

9. Endothelial Dysfunction Market Analysis - by End User

10. Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Geographic Analysis

11. Impact Of COVID-19 Pandemic on Endothelial Dysfunction Market

12. Endothelial Dysfunction Market-Industry Landscape

13. Company Profiles

14. Appendix

内皮機能障害の2028年までの市場予測-原因、検査タイプ、エンドユーザー別の世界分析

Endothelial Dysfunction Market Forecast to 2028 - Global Analysis by Cause, Test Type, and End User

目次

第1章 イントロダクション

第2章 内皮機能障害市場-主要な要点

第3章 調査手法

第4章 内皮機能障害市場- 市場情勢

第5章 内皮機能障害市場：主要市場力学

第6章 内皮機能障害市場-世界分析

第7章 内皮機能障害市場の分析-原因別

第8章 内皮機能障害市場の分析-検査タイプ別

第9章 内皮機能障害市場の分析-エンドユーザー別

第10章 内皮機能障害市場：2028年までの収益と予測：地域分析

第11章 内皮機能障害市場へのCOVID-19パンデミックの影響

第12章 内皮機能障害市場-業界情勢

第13章 企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

4. Endothelial Dysfunction Market - Market Landscape

5. Endothelial Dysfunction Market - Key Market Dynamics

6. Endothelial Dysfunction Market - Global Analysis

7. Endothelial Dysfunction Market Analysis - by Cause

8. Endothelial Dysfunction Market Analysis - by Test Type

9. Endothelial Dysfunction Market Analysis - by End User

10. Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Geographic Analysis

11. Impact Of COVID-19 Pandemic on Endothelial Dysfunction Market

12. Endothelial Dysfunction Market-Industry Landscape

13. Company Profiles

14. Appendix

第1章イントロダクション

第2章内皮機能障害市場-主要な要点

第3章調査手法

第4章内皮機能障害市場- 市場情勢

第5章内皮機能障害市場：主要市場力学

第6章内皮機能障害市場-世界分析

第7章内皮機能障害市場の分析-原因別

第8章内皮機能障害市場の分析-検査タイプ別

第9章内皮機能障害市場の分析-エンドユーザー別

第10章内皮機能障害市場：2028年までの収益と予測：地域分析

第11章内皮機能障害市場へのCOVID-19パンデミックの影響

第12章内皮機能障害市場-業界情勢

第13章企業プロファイル

第14章付録